Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.63 |
| ▸ | AKT1 | P31749 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2401509 | 1.00 | TSHR (0.63) | TSHRAKT1LMNAALDH1A1KMT2A | |
| SCHEMBL9188658 | 1.00 | TSHR (0.63) | TSHRAKT1LMNAALDH1A1KMT2A | |
| SCHEMBL11332980 | 0.93 | TSHR (0.56) | TSHRAKT1LMNAALDH1A1EPHX2 | |
| SCHEMBL9449027 | 0.91 | TSHR (0.52) | TSHRAKT1LMNAALDH1A1KMT2A | |
| SCHEMBL6220022 | 0.91 | TSHR (0.52) | TSHRAKT1LMNAALDH1A1KMT2A | |
| SCHEMBL23706440 | 0.91 | TSHR (0.52) | TSHRAKT1LMNAALDH1A1KMT2A | |
| SCHEMBL3084656 | 0.91 | TSHR (0.52) | TSHRAKT1LMNAALDH1A1KMT2A | |
| SCHEMBL3506096 | 0.91 | TSHR (0.52) | TSHRAKT1LMNAALDH1A1KMT2A | |
| SCHEMBL21594794 | 0.91 | TSHR (0.52) | TSHRAKT1LMNAALDH1A1KMT2A | |
| SCHEMBL11526688 | 0.91 | TSHR (0.52) | TSHRAKT1LMNAALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119552102-A | Synthesis method of dialkyl selenoether compound | 西安交通大学 | 2025-03-04 | — | — | CN | disclosed |
| US-9676676-B2 | Selective olefin metathesis with cyclometalated ruthenium complexes | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-06-13 | — | — | US | disclosed |
| US-20160185684-A1 | SELECTIVE OLEFIN METATHESIS WITH CYCLOMETALATED RUTHENIUM COMPLEXES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-06-30 | — | — | US | disclosed |
| WO-2011110349-A2 | PROCESS FOR THE PREPARATION OF DICARBOXYLIC ACIDS OR DICARBOXYLIC ACID ESTERS BY METATHESIS | EMERY OLEOCHEMICALS GMBH (DE) | 2011-09-15 | — | — | WO | disclosed |
| US-6828464-B2 | Preparation of cyclopentenones | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-07 | — | — | US | disclosed |
| US-20040102655-A1 | Preparation of cyclopentenoes | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-27 | — | — | US | disclosed |
| EP-0440251-B1 | Process for preparing optically active cyclopentenones | SUMITOMO CHEMICAL CO (JP) | 1995-09-06 | — | — | EP | disclosed |
| US-5191109-A | Process for preparing optically active cyclopentenones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-02 | — | — | US | disclosed |
| EP-0440251-A2 | Process for preparing optically active cyclopentenones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-08-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102655-A1 | Preparation of cyclopentenoes | CYP17A1, CYP2F1, CYP2S1 | TSHR 3431/4885AKT1 2899/4885LMNA 3150/4885 |
| US-20160185684-A1 | SELECTIVE OLEFIN METATHESIS WITH CYCLOMETALATED RUTHENIUM COMPLEXES | ZDHHC7, COASY, ZDHHC2 | TSHR 4341/4885AKT1 522/4885LMNA 4775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.